Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy.

CONCLUSION: The prevalence of FSD and HSDD after RRSO was 74% and 73% respectively. Relationship satisfaction, low bodily pain and use of topical vaginal estrogen were associated with a lower likelihood of sexual dysfunction. There was no correlation between serum testosterone or FAI, and sexual dysfunction. PMID: 26545955 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26545955?dopt=Abstract

Source: Gynecologic Oncology - November 3, 2015 Category: Cancer & Oncology Authors: Tucker PE, Bulsara MK, Salfinger SG, Tan JJ, Green H, Cohen PA Tags: Gynecol Oncol Source Type: research